Interestingly, in cervical cancer, MEG3 expression is inversely associated to tumor volume and metastasis, which indicates its strong role as a tumor suppressor through P53 and pointing out as a possible therapeutic target [91]. The gene discussed is TP53; the disease is neoplasm.